286 related articles for article (PubMed ID: 25459070)
41. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
42. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
43. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
[TBL] [Abstract][Full Text] [Related]
44. Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
Kozak MM; von Eyben R; Gutkin PM; Vemuri M; Jacobson CE; Karl JJ; Walck E; Marquez C; Horst KC
Clin Breast Cancer; 2021 Aug; 21(4):373-382. PubMed ID: 33766533
[TBL] [Abstract][Full Text] [Related]
45. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.
Shirvani SM; Pan IW; Buchholz TA; Shih YC; Hoffman KE; Giordano SH; Smith BD
Cancer; 2011 Oct; 117(20):4595-605. PubMed ID: 21710653
[TBL] [Abstract][Full Text] [Related]
46. Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.
Min SY; Lee SJ; Shin KH; Park IH; Jung SY; Lee KS; Ro J; Lee S; Kim SW; Kim TH; Kang HS; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e697-705. PubMed ID: 21129858
[TBL] [Abstract][Full Text] [Related]
47. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy.
Keruakous AR; Sadek BT; Shenouda MN; Niemierko A; Abi Raad RF; Specht M; Smith BL; Taghian AG
Breast Cancer Res Treat; 2014 Jul; 146(2):365-70. PubMed ID: 24952906
[TBL] [Abstract][Full Text] [Related]
48. Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival.
Woodward WA; Truong PT; Yu TK; Tereffe W; Oh J; Perkins G; Strom E; Meric-Bernstam F; Gonzalez-Angulo AM; Speers C; Ragaz J; Buchholz TA
Breast Cancer Res Treat; 2010 Sep; 123(2):597-605. PubMed ID: 20306128
[TBL] [Abstract][Full Text] [Related]
49. Post-Mastectomy Radiation Therapy in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients: Analysis of the HERA Trial.
Abi Jaoude J; de Azambuja E; Makki M; Tamim H; Tfayli A; Geara F; Piccart M; Poortmans P; Zeidan YH
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):503-510. PubMed ID: 31654782
[TBL] [Abstract][Full Text] [Related]
50. Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapy.
Huang CJ; Hou MF; Chuang HY; Lian SL; Huang MY; Chen FM; Fu OY; Lin SF
Jpn J Clin Oncol; 2012 Aug; 42(8):711-20. PubMed ID: 22645150
[TBL] [Abstract][Full Text] [Related]
51. Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer.
Vargo JA; Beriwal S; Ahrendt GM; Soran A; Johnson RR; McGuire K; Bhargava R
Oncology; 2011; 80(5-6):341-9. PubMed ID: 21791944
[TBL] [Abstract][Full Text] [Related]
52. Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic Management.
Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
Clin Breast Cancer; 2015 Aug; 15(4):e197-204. PubMed ID: 25957739
[TBL] [Abstract][Full Text] [Related]
53. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
[TBL] [Abstract][Full Text] [Related]
54. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
[TBL] [Abstract][Full Text] [Related]
55. Comparison of Long-Term Outcomes of Postmastectomy Radiotherapy between Breast Cancer Patients with and without Immediate Flap Reconstruction.
Lee HH; Hou MF; Wei SY; Lin SD; Luo KH; Huang MY; Ou-Yang F; Huang CJ
PLoS One; 2016; 11(2):e0148318. PubMed ID: 26863006
[TBL] [Abstract][Full Text] [Related]
56. Prediction of margin involvement and local recurrence after skin-sparing and simple mastectomy.
Al-Himdani S; Timbrell S; Tan KT; Morris J; Bundred NJ
Eur J Surg Oncol; 2016 Jul; 42(7):935-41. PubMed ID: 27256869
[TBL] [Abstract][Full Text] [Related]
57. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.
Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H
Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606
[TBL] [Abstract][Full Text] [Related]
58. Post-mastectomy Radiation: Should Subtype Factor into the Decision?
Scheer AS; Zih FS; Maki E; Koch CA; McCready DR
Ann Surg Oncol; 2016 Aug; 23(8):2462-70. PubMed ID: 27008587
[TBL] [Abstract][Full Text] [Related]
59. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
[TBL] [Abstract][Full Text] [Related]
60. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
